Armodafinil
Discover related
5 sources
🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Sodium-dependent dopamine transporter (SLC6A3) | Inhibitor | 5.497 IC50 | DRUGCENTRAL | TargetSodium-dependent dopamine transporter (SLC6A3) ActionInhibitor Affinity5.497 IC50 SourceDRUGCENTRAL |
| Alpha-1B adrenergic receptor (ADRA1B) | — | — | DRUGCENTRAL | TargetAlpha-1B adrenergic receptor (ADRA1B) Action— Affinity— SourceDRUGCENTRAL |
| Cytochrome P450 1A2 (CYP1A2) | — | — | DRUGCENTRAL | TargetCytochrome P450 1A2 (CYP1A2) Action— Affinity— SourceDRUGCENTRAL |
| Cytochrome P450 2C19 (CYP2C19) | — | — | DRUGCENTRAL | TargetCytochrome P450 2C19 (CYP2C19) Action— Affinity— SourceDRUGCENTRAL |
| D(2) dopamine receptor (DRD2) | — | 6.921 EC50 | DRUGCENTRAL | TargetD(2) dopamine receptor (DRD2) Action— Affinity6.921 EC50 SourceDRUGCENTRAL |
| D(3) dopamine receptor (DRD3) | — | 4.41 Ki | DRUGCENTRAL | TargetD(3) dopamine receptor (DRD3) Action— Affinity4.41 Ki SourceDRUGCENTRAL |
| Sodium-dependent dopamine transporter (Slc6a3) | — | 5.49 Ki | DRUGCENTRAL | TargetSodium-dependent dopamine transporter (Slc6a3) Action— Affinity5.49 Ki SourceDRUGCENTRAL |
External links
Source: DrugCentral — Armodafinil ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.